🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study aims to evaluate whether \^68Ga-TROP2 PET/CT, combined with \^18...
Status
Recruiting
Location
Fudan University Shanghai Cancer Center
Start Date
2026-03-11
Trial ID
NCT07471776
This is a Phase III, 2-arm, randomised, open-label, multicentre, global stu...
Status
Active Not Recruiting
Location
Research Site
Start Date
2023-11-14
Trial ID
NCT06112379
This is a Phase Ib/II, open-label, multi-cohort, multi-center study to eval...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-08-01
Trial ID
NCT07738341
Treatments Being Tested
This is a Phase II, interventional, prospective, single-arm, multi-center s...
Status
Recruiting
Location
UNC Lineberger Comprehensive Cancer Center
Start Date
2026-02-26
Trial ID
NCT07069595
Treatments Being Tested
The purpose of this study is to test the safety and effectiveness of the st...
Status
Recruiting
Location
Miami Baptist Cancer Institute/
Start Date
2024-01-08
Trial ID
NCT06176261
Treatments Being Tested
Purpose: to assess efficacy and safety of Dato-DXd + rilvegostomig as adjuv...
Status
Recruiting
Location
Research Site
Start Date
2026-07-16
Trial ID
NCT07720284
Treatments Being Tested
TROPION-Lung17 will measure the efficacy and safety of datopotamab deruxtec...
Status
Recruiting
Location
Research Site
Start Date
2025-10-31
Trial ID
NCT07291037
Treatments Being Tested
This is a first time in human (FTiH) Phase I/IIa, open-label, multi-centre ...
Status
Recruiting
Location
Research Site
Start Date
2024-01-18
Trial ID
NCT06130553
Treatments Being Tested
This is a Phase III, randomised, open-label, 2 arm, multicentre, internatio...
Status
Active Not Recruiting
Location
Research Site
Start Date
2022-05-16
Trial ID
NCT05374512
Treatments Being Tested
Choice Of the Most Active Strategies for Short term recurring Triple Negati...
Status
Recruiting
Location
Gustave Roussy
Start Date
2024-07-05
Trial ID
NCT06508216
Treatments Being Tested